
新常态下我国医药产业供给侧结构性改革探讨
李 波1,2,孙利华1*
新常态下我国医药产业供给侧结构性改革探讨
Discussion on Structural Reform of Supply-side of Pharmaceutical Industry under New Normal
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |